본문 바로가기

The effect of neoadjuvant chemotherapy on survival outcomes subsequent to radical cystectomy in pathological T0 bladder cancer patients: A multicenter large-scale analysis

문서 유형
연구출판물 · 학술지 논문
등재
KCISCIEScopus
저널 순위
JCR Q2Scopus Q2KCI Q3
저널
Investigative and Clinical Urology66(5) · pp.395 · 2025
피인용
Web of Science 3Scopus 3KCI 0
FWCI (Scopus)
1.34
JCR IF
JCR 2024 2.1
ISSN
2466-0493

저자

  1. Park, Jong Ho제1저자Seoul Natl Univ, Bundang Hosp, Dept Urol, 82 Gumi Ro,173 Beon Gil, Seongnam 13620, South Korea
  2. Lee, SangchulSeoul Natl Univ, Bundang Hosp, Dept Urol, 82 Gumi Ro,173 Beon Gil, Seongnam 13620, South Korea
  3. Jeong, Seung-hwanSeoul Natl Univ Hosp, Dept Urol, Seoul, South Korea
  4. Ku, Ja HyeonSeoul Natl Univ Hosp, Dept Urol, Seoul, South Korea
  5. 김경환Pusan Natl Univ Hosp, Dept Urol, Busan, South Korea
  6. 남종길Pusan Natl Univ, Yangsan Hosp, Dept Urol, Yangsan, South Korea
  7. Lim, BumjinUniv Ulsan, Coll Med, Asan Med Ctr, Dept Urol, Seoul, South Korea
  8. Hong, Bum SikUniv Ulsan, Coll Med, Asan Med Ctr, Dept Urol, Seoul, South Korea
  9. Nam, WookUniv Ulsan, Coll Med, Gangneung Asan Hosp, Dept Urol, Kangnung, South Korea
  10. Kang, Sung GuKorea Univ, Coll Med, Dept Urol, Seoul, South Korea
  11. Kang, Seok HoKorea Univ, Coll Med, Dept Urol, Seoul, South Korea
  12. Kwon, Tae GyunKyungpook Natl Univ, Sch Med, Dept Urol, Daegu, South Korea
  13. Kim, Tae-HwanKyungpook Natl Univ, Sch Med, Dept Urol, Daegu, South Korea
  14. Heo, JieunYonsei Univ, Coll Med, Dept Urol, Seoul, South Korea
  15. Ham, Won SikYonsei Univ, Coll Med, Dept Urol, Seoul, South Korea
  16. Song, GeehyunNatl Canc Ctr, Ctr Urol Canc, Dept Urol, Goyang, South Korea
  17. Seo, Ho KyungNatl Canc Ctr, Ctr Urol Canc, Dept Urol, Goyang, South Korea
  18. Song, WanSungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Urol, Seoul, South Korea
  19. Sung, Hyun HwanSungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Urol, Seoul, South Korea
  20. Jeong, Byong ChangSungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Urol, Seoul, South Korea
  21. Oh, Jong Jin교신저자Seoul Natl Univ, Bundang Hosp, Dept Urol, 82 Gumi Ro,173 Beon Gil, Seongnam 13620, South Korea

초록

Purpose: After radical cystectomy (RC), the pathologic complete response (pT0) among muscle-invasive bladder cancer (MIBC) is considered a favorable oncological result. The objective of this study was to evaluate the effect of neoadjuvant chemotherapy (NAC) among the pT0 patients using a large-scale multicenter study. Materials and Methods: This study included 3,972 patients who underwent RC at 11 tertiary medical centers. Analysis was conducted on patients with MIBC who achieved a pT0, with a focus on comparing results between those who received NAC and those who did not. Recurrence-free survival (RFS), cancer-specific survival (CSS), and overall survival (OS) were analyzed in these groups. Results: Among 252 eligible pT0 patients, 121 were categorized in the non-NAC group while the remaining 131 were in the NAC group. As compared to the non-NAC group, the NAC group demonstrated significantly better survival outcomes, with 5-year RFS rates of 89% vs. 80% (p=0.043), OS rates of 84% vs. 69% (p=0.011), and CSS rates of 95% vs. 80% (p=0.007). Multivariable Cox proportional hazards analyses demonstrated that NAC independently improved RFS (hazard ratio [HR] 0.192, p=0.002) and CSS (HR 0.200, p=0.020), but not OS (HR 0.672, p=0.263). Conclusions: In patients with MIBC who achieved a pT0, NAC administration prior to RC has a positive impact on oncological prognosis. Although further prospective studies are needed for validation, the results of this study will confirm the importance of NAC in MIBC.

키워드

CystectomyNeoadjuvant therapySurvival analysisUrinary bladder neoplasmsADJUVANT CHEMOTHERAPYEAU GUIDELINESMUSCLECARCINOMA

식별자

Scopus EID
2-s2.0-105015327789
WoS UID
001545605700001
KCI
ART003239671